BCR-ABL-IN-7
BCR-ABL-IN-7 is a WT and T315I mutant ABL kinase inhibitor.BCR-ABL-IN-7 potently inhibits WT and T315I mutant ABL kinase activity.BCR-ABL-IN-7 can be used in chronic myelogenous leukemia (CML) research.
Product Specifications
CAS Number
688050-42-2
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
385.41
Molecular Formula
C19H16FN3O3S
Notes
Research use only, not for human use.
Receptor
Bcr-Abl
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
F4206-01L-ML650 100 µL
FGB, CT (Fibrinogen beta chain, Fibrinopeptide B) (MaxLight 650) discontinued
Ask
View Details 